Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2345${count})

  • Rapid Response Innovation Awards, 2013
    Transcranial Direct Current Stimulation for the Treatment of Parkinson’s Disease

    Objective/Rationale:
    Current treatments for Parkinson’s disease (PD) are either associated with side effects, expensive, or their efficacy diminishes over time. Thus, the development of practical...

  • MJFF Research Grant, 2013
    A New Tool for CSF-Based Parkinson Disease Diagnostics: Super-Resolution Microscopy Investigation of Alpha-Synuclein Aggregates

    Objective/Rationale:             
    It is still difficult to diagnose Parkinson’s Disease (PD) patients through routine assays. Clinical research on PD suggests that the aggregation (clumping) of the...

  • Target Validation, 2013
    Validation of the Transcriptional Repressor Bach1 as a Novel Target to Enhance Antioxidant Response Pathway and Block Neurodegeneration in Parkinson’s Disease

    Objective/Rationale:             
    Bach1 is a transcriptional repressor, which is a protein that binds to a specific DNA site and prevents transcription of nearby genes. Bach1 is primarily localized to...

  • RRIA (Rapid Response Innovation Awards), 2013
    Proof-of-concept Study for the Development of Non-invasive Immunotherapy for Parkinson’s Disease: Intranasal Targeting of Immunoglobulin G Antibodies and Fragments to the CNS

    Objective/Rationale:             
    Immunotherapy using antibodies directed against alpha-synuclein is an extraordinarily promising, potentially disease-modifying treatment approach for Parkinson’s...

  • LRRK2 Challenge, 2013
    LRRK2 and Vitamin D3 Metabolism

    Objective/Rationale:             
    The LRRK2 kinase enzyme is mutated in some patients with Parkinson’s disease (PD). Coincidentally, the kinase is widely expressed in most organs of the body. We...

  • Target Validation, 2013
    Significance of Miro in the Pathogenesis of Parkinson's Disease

    Objective/Rationale:             
    Miro is a protein on the outer membrane of mitochondria. Miro anchors kinesin motor proteins to mitochondria; the kinesins transport mitochondria to where they need...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.